LoginRegister
    FDA approves Pfizer drug for advanced breast cancerFDA approves Pfizer drug for advanced breast cancer
    Alembic Pharma gets USFDA nod for diabetes drug AlogliptinAlembic Pharma gets USFDA nod for diabetes drug Alogliptin
    Multiple sclerosis drug: US court invalidates Tevas patent; boost for Natco, MylanMultiple sclerosis drug: US court invalidates Teva's patent; boost for Natco, Mylan
    Singh brothers, 8 other entities told to repay over Rs 403 crore to Fortis Healthcare: SEBISingh brothers, 8 other entities told to repay over Rs 403 crore to Fortis Healthcare: SEBI
    Bengaluru: Mylan Hackathon 2018 Winners announcedBengaluru: Mylan Hackathon 2018 Winners announced
    Dr Reddy donates Rs 25 lakhs to Kerala CM distress Relief fundDr Reddy donates Rs 25 lakhs to Kerala CM distress Relief fund
    Cost of blood pressure drug surges in U.S. after recallCost of blood pressure drug surges in U.S. after recall
    Sanofi, Regeneron say late-stage Dupixent trials show positive results in Asthma TreatmentSanofi, Regeneron say late-stage Dupixent trials show positive results in Asthma Treatment
    Sanofi, Novo Nordisk Eli Lilly accused of deceptive drug pricing of InsulinSanofi, Novo Nordisk Eli Lilly accused of deceptive drug pricing of Insulin
    Alembic Pharma gets USFDA nod for diabetes drugAlembic Pharma gets USFDA nod for diabetes drug
    Haryana: KARNAL to get Mega pharma park, says govtHaryana: KARNAL to get Mega pharma park, says govt
    China fines pharma firm $1.3 billion in vaccine scandalChina fines pharma firm $1.3 billion in vaccine scandal
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X